The ROE (Return on Equity) of Enzon Pharmaceuticals Inc (ENZN) is 1.71%.
ROE (Return on Equity) shows how effectively a company utilizes shareholders equity to produce earnings. It serves as a key indicator of financial return for investors.
| Date | Value |
|---|---|
| 2024-12-31 | 1.71% |
| 2023-12-31 | 2.99% |
| 2022-12-31 | -0.44% |
| 2021-12-31 | -1.05% |
| 2020-12-31 | -2.72% |
| 2019-12-31 | -16.39% |
| 2018-12-31 | 38.67% |
| 2017-12-31 | 59.34% |
| 2016-12-31 | -10.68% |
| 2015-12-31 | 119.34% |